Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rücker

Showing results (701-710 of 726) with videos related to

Pageof 73
Sort By:
Frontiers in Microbiology|April 25, 2020
A Placenta Derived C-Terminal Fragment of β-Hemoglobin With Combined Antibacterial and Antiviral ActivityRüdiger Groß, Richard Bauer, Franziska Krüger, et al.
British Journal of Haematology|January 16, 2016
TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantationJan M Middeke, Sylvia Herold, Elke Rücker-Braun, et al.
Science (New York, N.Y.)|August 10, 2019
A dominant-negative effect drives selection of <i>TP53</i> missense mutations in myeloid malignanciesSteffen Boettcher, Peter G Miller, Rohan Sharma, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|December 31, 2021
Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: a cardiovascular magnetic resonance based multicenter international study-the CARDOVID registryFlorence A Aeschlimann, Nilanjana Misra, Tarique Hussein, et al.
Deutsche Medizinische Wochenschrift (1946)|September 25, 1981
[Treatment of Wilms' tumor (author's transl)]E Pichler, O A Jürgenssen, G Reinartz, et al.
Blood Advances|January 23, 2023
Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemiaFalk Heidenreich, Bose Falk, Henning Baldauf, et al.
Thrombosis and Haemostasis|December 31, 2024
Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation: Rationale and Design for PRESTIGE-AF TrialEleni Korompoki, Peter Heuschmann, Kirsten H Harvey, et al.
Blood|September 27, 2019
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study GroupFrank G Rücker, Mridul Agrawal, Andrea Corbacioglu, et al.
European Journal of Neurology|February 23, 2021
Impact of the coronavirus disease 2019 pandemic on stroke teleconsultations in Germany in the first half of 2020Christoph Vollmuth, Olga Miljukov, Mazen Abu-Mugheisib, et al.
Blood Cancer Discovery|October 17, 2023
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor CellsAnnika Nelde, Heiko Schuster, Jonas S Heitmann, et al.
Pageof 73

Showing results (701-710 of 726) with videos related to

Sort By:
Pageof 73
Frontiers in Microbiology|April 25, 2020
A Placenta Derived C-Terminal Fragment of β-Hemoglobin With Combined Antibacterial and Antiviral ActivityRüdiger Groß, Richard Bauer, Franziska Krüger, et al.
British Journal of Haematology|January 16, 2016
TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantationJan M Middeke, Sylvia Herold, Elke Rücker-Braun, et al.
Science (New York, N.Y.)|August 10, 2019
A dominant-negative effect drives selection of <i>TP53</i> missense mutations in myeloid malignanciesSteffen Boettcher, Peter G Miller, Rohan Sharma, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|December 31, 2021
Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: a cardiovascular magnetic resonance based multicenter international study-the CARDOVID registryFlorence A Aeschlimann, Nilanjana Misra, Tarique Hussein, et al.
Deutsche Medizinische Wochenschrift (1946)|September 25, 1981
[Treatment of Wilms' tumor (author's transl)]E Pichler, O A Jürgenssen, G Reinartz, et al.
Blood Advances|January 23, 2023
Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemiaFalk Heidenreich, Bose Falk, Henning Baldauf, et al.
Thrombosis and Haemostasis|December 31, 2024
Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation: Rationale and Design for PRESTIGE-AF TrialEleni Korompoki, Peter Heuschmann, Kirsten H Harvey, et al.
Blood|September 27, 2019
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study GroupFrank G Rücker, Mridul Agrawal, Andrea Corbacioglu, et al.
European Journal of Neurology|February 23, 2021
Impact of the coronavirus disease 2019 pandemic on stroke teleconsultations in Germany in the first half of 2020Christoph Vollmuth, Olga Miljukov, Mazen Abu-Mugheisib, et al.
Blood Cancer Discovery|October 17, 2023
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor CellsAnnika Nelde, Heiko Schuster, Jonas S Heitmann, et al.
Pageof 73